UCSF researchers find evidence of faulty DNA repair in some infertile men

May 31, 2000

Some infertile men have mutations or errors in their DNA code, suggesting that faulty DNA repair may be a reason for their infertility, according to UC San Francisco researchers.

Moreover, this kind of DNA repair problem is similar to that found in certain kinds of cancer patients, and is linked to the abnormal growth of tumor cells. This finding has prompted the UCSF researchers to wonder if some infertile men could pass the problem of faulty DNA repair to offspring conceived through high technology- assisted reproduction methods. If so, this could potentially increase the risk of these children also being infertile, and might also predispose them to developing cancer, according to the researchers.

The research will be published in the June edition of the British journal Human Reproduction. The research, which was a small study of ten men, was performed in the laboratory of Renee Reijo Pera, MD, UCSF assistant professor in the departments of Obstetrics, Gynecology and Reproductive Sciences, Urology, Human Genetics and Physiology.

"The conclusion is that some male infertility may be related to a larger problem of defective DNA repair. This is encouraging news because it helps us explain why some men are infertile. What is worrisome, though, is that defective DNA repair has a long association with cancer," said Paul Turek, MD, another study author and UCSF associate professor of urology. "The implications are that maybe infertility is not a minor problem. Maybe there is a very good reason for men to be infertile."

Of all couples in America who are trying to conceive, 20 percent cannot, Turek said. Among those, half are due to male factor infertility. And many of the cases of male infertility are unexplained, Turek said. Common causes of male infertility include dilated veins in the scrotum (varicoceles), infections and toxin exposure.

"A significant portion of the infertility we can't explain now is probably going to end up being genetic," Turek said. "That's a lot of people." In addition, other researchers in the past have discovered that certain cancers, including a form of colon cancer, are associated with defective DNA repair. In 1995, the journal Cell published two papers in which the genes responsible for DNA repair in mice were altered to see what happened. The mice developed tumors, as was expected. But the mice also became infertile, which was not expected.

" We wondered if infertile men with failing testicles that had a "look" similar to the testes from the altered mice would also show defective DNA repair," Reijo Pera said. "We asked if the testis tissue of these infertile men showed certain "fingerprints" characteristic of a problem repairing DNA."

The current UCSF study included five men with normally functioning testes and five whose testes made little or no sperm, also called testes failure. Investigators sequenced testes tissue DNA from both groups and found an increased frequency of certain DNA mutations or errors in the group with testes failure. These men had 100-fold higher error rate in their DNA than the men with normally functioning testes, Reijo Pera said.

This small study may help explain some cases of male infertility, but also raises several questions, Turek said. The findings need to be expanded to include many more infertile men to get a feel for the real impact of the research, he said.

Also, given what scientists know about defective DNA repair and cancer, researchers need to pay attention to what the consequences of this might be for infertile couples, Turek said. One concern is the health of pregnancies and children conceived with assisted reproductive techniques, such as intracytoplasmic sperm injection (ICSI) in cases of male infertility due to testes failure. This precise technique helps couples with severe male factor infertility have babies by injecting a single live sperm directly into the center of a human egg. The technique is very powerful because it can be used with sperm from the testes where they are made, as well as from the ejaculate.

"With ICSI, natural selection barriers that normally exist during conception may be broken down. If a couple has a genetic problem, it may be transmitted to children in a way that might not occur normally." Turek said. "At this time, it is not at all clear whether a problem like this, that exists in the sex cells of an infertile man, will be seen at all in his offspring if ICSI is used." Perhaps problems with DNA repair will not be passed along to children conceived through ICSI because such problems may simply result in miscarriages. Defective DNA repair is also commonly found in spontaneously aborted embryos, Reijo Pera said, suggesting babies who make it to term would not have this problem.

Alternatively, children with DNA repair defects may survive to term. Theoretically, they could then have an increased risk of infertility, or possibly even tumor formation later in life, according to the study. "We don't know which scenario will be true." Turek said.

Turek said researchers should follow-up on the health and development of ICSI children in couples with severe male factor infertility from testes failure to help sort out these issues.
Other study authors are: David Nudell, MD, a surgeon-in-training in the UCSF Department of Urology and Michael Castillo, staff research associate in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences. The study was funded by the National Institutes of Health, the University of California Campus Laboratory Collaboration, UCSF-Stanford Healthcare and the California Urological Foundation.

University of California - San Francisco

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.